U.S. researchers working on lab cultures were able to halt the spread of human ovarian cancer cells by using RNA interference and small-interfering RNA to inhibit proteins made by an oncogene called MYC. The scientists also applied RNAi and siRNA to normal ovarian surface epithelial cells but found no changes, leading them to think that such therapies may work only on tumor cells with overly active MYC genes.

Full Story:

Related Summaries